Bedel Financial Consulting, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,100 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$473,248
+10.1%
4,4450.0%0.07%
+3.0%
Q1 2024$429,995
-4.2%
4,4450.0%0.07%
-18.3%
Q4 2023$448,843
-0.9%
4,4450.0%0.08%
-10.9%
Q3 2023$452,800
+0.9%
4,4450.0%0.09%
-2.1%
Q2 2023$448,577
+13.6%
4,445
+3.6%
0.09%
-2.1%
Q1 2023$394,893
+10.0%
4,292
+8.4%
0.10%
+7.9%
Q4 2022$359,098
+25.1%
3,958
+12.9%
0.09%
+17.1%
Q3 2022$287,000
+103.5%
3,506
+119.0%
0.08%
+72.7%
Q1 2022$141,000
+3.7%
1,601
+2.8%
0.04%
+4.8%
Q4 2021$136,000
+10.6%
1,558
+4.0%
0.04%0.0%
Q3 2021$123,000
-10.2%
1,4980.0%0.04%
-12.5%
Q2 2021$137,000
+7.0%
1,4980.0%0.05%
-4.0%
Q1 2021$128,000
+42.2%
1,498
+56.9%
0.05%
+25.0%
Q4 2020$90,000
+7.1%
955
-0.6%
0.04%
-4.8%
Q3 2020$84,0000.0%9610.0%0.04%
-6.7%
Q2 2020$84,000
+6.3%
9610.0%0.04%
-13.5%
Q1 2020$79,000
-2.5%
961
+12.4%
0.05%
+13.0%
Q4 2019$81,000
+9.5%
8550.0%0.05%
+2.2%
Q3 2019$74,000
-5.1%
8550.0%0.04%
-4.3%
Q2 2019$78,000
-6.0%
855
-0.6%
0.05%
-11.3%
Q1 2019$83,000
+13.7%
860
+0.6%
0.05%0.0%
Q4 2018$73,0000.0%8550.0%0.05%
+8.2%
Q3 2018$73,000
+12.3%
8550.0%0.05%
+2.1%
Q2 2018$65,000
-5.8%
8550.0%0.05%
-7.7%
Q1 2018$69,0008550.05%
Other shareholders
NOVARTIS A G shareholders Q2 2019
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders